ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 160 filers reported holding ARRAY BIOPHARMA INC in Q3 2015. The put-call ratio across all filers is 1.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $4,278,000 | +400.9% | 92,346 | +54.0% | 0.06% | +460.0% |
Q4 2018 | $854,000 | +238.9% | 59,984 | +261.3% | 0.01% | +233.3% |
Q3 2018 | $252,000 | -9.4% | 16,600 | 0.0% | 0.00% | -25.0% |
Q2 2018 | $278,000 | -49.8% | 16,600 | -51.2% | 0.00% | -42.9% |
Q1 2018 | $554,000 | -85.0% | 34,000 | -88.2% | 0.01% | -81.6% |
Q4 2017 | $3,693,000 | +30.8% | 288,600 | +25.7% | 0.04% | +22.6% |
Q3 2017 | $2,824,000 | +53.6% | 229,600 | +4.6% | 0.03% | +34.8% |
Q2 2017 | $1,838,000 | -14.3% | 219,600 | -8.5% | 0.02% | -32.4% |
Q1 2017 | $2,144,000 | +11.0% | 240,000 | +9.1% | 0.03% | +36.0% |
Q4 2016 | $1,932,000 | +37.6% | 219,900 | +5.7% | 0.02% | +19.0% |
Q3 2016 | $1,404,000 | +156.7% | 208,100 | +35.3% | 0.02% | +162.5% |
Q2 2016 | $547,000 | +21.8% | 153,800 | +4193.7% | 0.01% | -38.5% |
Q1 2016 | $449,000 | +87.1% | 3,582 | +33.6% | 0.01% | +160.0% |
Q4 2015 | $240,000 | +133.0% | 2,682 | +194.7% | 0.01% | +150.0% |
Q3 2015 | $103,000 | -20.8% | 910 | -61.2% | 0.00% | -33.3% |
Q2 2015 | $130,000 | -16.1% | 2,346 | +19.2% | 0.00% | -25.0% |
Q1 2015 | $155,000 | +416.7% | 1,968 | +47.2% | 0.00% | +300.0% |
Q4 2014 | $30,000 | -88.7% | 1,337 | -77.6% | 0.00% | -83.3% |
Q3 2014 | $266,000 | +1377.8% | 5,977 | +2400.8% | 0.01% | – |
Q2 2014 | $18,000 | -92.2% | 239 | -93.7% | 0.00% | -100.0% |
Q1 2014 | $230,000 | +198.7% | 3,818 | +66.8% | 0.01% | +150.0% |
Q4 2013 | $77,000 | -63.5% | 2,289 | -66.6% | 0.00% | -60.0% |
Q3 2013 | $211,000 | – | 6,863 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |